Paul Gerson Unschuld

From Biomarker to Bedside: Integrated Care as the Real Innovation in Alzheimer’s Disease

For decades, clinicians treating Alzheimer’s disease could offer accurate diagnosis, symptomatic drugs, and compassionate support, but nothing that altered the course of the disease [...]